Our top pick for
Building a portfolio
RELX PLC is a publishing business based in the US. RELX shares (RELX) are listed on the NYSE and all prices are listed in US Dollars. RELX employs 33,200 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$19.52 - $27.15|
|50-day moving average||$25.36|
|200-day moving average||$24.17|
|Wall St. target price||$2,024.56|
|Dividend yield||$0.47 (1.75%)|
|Earnings per share (TTM)||$0.88|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing RELX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of RELX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
RELX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, RELX shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
RELX's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1136. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into RELX's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
RELX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.1 billion.
The EBITDA is a measure of a RELX's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$7.1 billion|
|Operating margin TTM||23.66%|
|Gross profit TTM||$4.6 billion|
|Return on assets TTM||7.53%|
|Return on equity TTM||56.3%|
|Market capitalisation||$52.1 billion|
TTM: trailing 12 months
There are currently 1.6 million RELX shares held short by investors – that's known as RELX's "short interest". This figure is 42.5% down from 2.8 million last month.
There are a few different ways that this level of interest in shorting RELX shares can be evaluated.
RELX's "short interest ratio" (SIR) is the quantity of RELX shares currently shorted divided by the average quantity of RELX shares traded daily (recently around 818082.14285714). RELX's SIR currently stands at 1.96. In other words for every 100,000 RELX shares traded daily on the market, roughly 1960 shares are currently held short.
However RELX's short interest can also be evaluated against the total number of RELX shares, or, against the total number of tradable RELX shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case RELX's short interest could be expressed as 0% of the outstanding shares (for every 100,000 RELX shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable RELX shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against RELX.
Find out more about how you can short RELX stock.
Dividend payout ratio: 1.67% of net profits
Recently RELX has paid out, on average, around 1.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.42% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), RELX shareholders could enjoy a 2.42% return on their shares, in the form of dividend payments. In RELX's case, that would currently equate to about $0.47 per share.
While RELX's payout ratio might seem low, this can signify that RELX is investing more in its future growth.
RELX's most recent dividend payout was on 7 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 April 2021 (the "ex-dividend date").
RELX's shares were split on a 4:1 basis on 30 June 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your RELX shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for RELX shares which in turn could have impacted RELX's share price.
Over the last 12 months, RELX's shares have ranged in value from as little as $19.52 up to $27.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while RELX's is 0.4596. This would suggest that RELX's shares are less volatile than average (for this exchange).
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.